BioNTech SE (BNTX) Notes Payables (2019 - 2023)
BioNTech SE (BNTX) posted Notes Payables of $2.5 million for Q4 2023, up 9.79% sequentially from $2.3 million in Q1 2023, and up 15.5% YoY from $2.1 million in Q4 2022.
BioNTech SE (BNTX) Notes Payables (2019 - 2023) Analysis & Trends
BioNTech SE has reported Notes Payables for 5 years, with the latest figure at $2.5 million in Q4 2023.
- Quarterly Notes Payables rose 15.5% year-over-year to $2.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $2.5 million (up 15.5% YoY) and the FY2023 annual result came in at $2.5 million, up 15.5% from the prior year.
- Notes Payables rose to $2.5 million in Q4 2023 per BNTX's latest filing, from $2.3 million in the prior quarter.
- Over five years, Notes Payables peaked at $344.9 million in Q4 2021 and troughed at $2.1 million in Q4 2022.
- A 5-year average of $167.1 million and a median of $197.4 million in 2022 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2021 and 2022: Notes Payables jumped 3078.92% in 2021, then tumbled 99.38% in 2022.
- Over 5 years, Notes Payables stood at $76.3 million in 2019, then plunged by 85.77% to $10.8 million in 2020, then surged by 3078.92% to $344.9 million in 2021, then sank by 99.38% to $2.1 million in 2022, then climbed by 15.5% to $2.5 million in 2023.
- According to Business Quant data, Notes Payables over the past three periods registered $2.5 million, $2.3 million, and $2.1 million for Q4 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.47 Mn |
| Mar 31, 2023 | 2.25 Mn |
| Dec 31, 2022 | 2.14 Mn |
| Sep 30, 2022 | 238.96 Mn |
| Jun 30, 2022 | 220.45 Mn |
| Mar 31, 2022 | 174.41 Mn |
| Dec 31, 2021 | 344.91 Mn |
| Sep 30, 2021 | 338.10 Mn |
| Jun 30, 2021 | 309.26 Mn |
| Mar 31, 2021 | 285.40 Mn |
| Dec 31, 2020 | 10.85 Mn |
| Dec 31, 2019 | 76.27 Mn |